145 related articles for article (PubMed ID: 32049443)
1. Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis.
Abd Own S; Höijer J; Hillerdahl G; Dobra K; Hjerpe A
Diagn Cytopathol; 2021 May; 49(5):606-614. PubMed ID: 32049443
[TBL] [Abstract][Full Text] [Related]
2. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
3. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology.
Chevrier M; Monaco SE; Jerome JA; Galateau-Salle F; Churg A; Dacic S
Cancer Cytopathol; 2020 Dec; 128(12):939-947. PubMed ID: 32678499
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
Paintal A; Raparia K; Zakowski MF; Nayar R
Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
[TBL] [Abstract][Full Text] [Related]
5. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit.
Segal A; Sterrett GF; Frost FA; Shilkin KB; Olsen NJ; Musk AW; Nowak AK; Robinson BW; Creaney J
Pathology; 2013 Jan; 45(1):44-8. PubMed ID: 23222247
[TBL] [Abstract][Full Text] [Related]
6. Utility of the cytological criteria in the diagnosis of malignant pleural mesothelioma: Making the bridge between theory and practice.
Mlika M; Yaiche R; Ayadi R; Braham E; Abdennadher M; Mezni F
Tunis Med; 2023 May; 101(5):497-501. PubMed ID: 38372516
[TBL] [Abstract][Full Text] [Related]
7. Cytological Assessment of Desmoplastic Malignant Pleural Mesothelioma in an Autopsy Case.
Kawamoto Y; Kure S; Katayama H; Kawahara K; Teduka K; Kunugi S; Onda M; Motoda N; Ohashi R
J Nippon Med Sch; 2023 Feb; 89(6):616-622. PubMed ID: 34840219
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.
Muruganandan S; Alfonso H; Franklin P; Shilkin K; Segal A; Olsen N; Reid A; de Klerk N; Musk AB; Brims F
Br J Cancer; 2017 Mar; 116(6):703-708. PubMed ID: 28196068
[TBL] [Abstract][Full Text] [Related]
9. Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: Ten Years of Clinical Experience in Relation to International Guidelines.
Hjerpe A; Abd-Own S; Dobra K
Arch Pathol Lab Med; 2018 Aug; 142(8):893-901. PubMed ID: 30040460
[TBL] [Abstract][Full Text] [Related]
10. The role of cytological evaluation of pleural fluid in diagnosing malignant mesothelioma.
Lovrenski A; Panjković M; Tegeltija D; Latinović LT; Krcedinac J
Med Pregl; 2012; 65(1-2):5-8. PubMed ID: 22452231
[TBL] [Abstract][Full Text] [Related]
11. Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma.
Pinelli V; Laroumagne S; Sakr L; Marchetti GP; Tassi GF; Astoul P
J Thorac Oncol; 2012 Mar; 7(3):595-8. PubMed ID: 22307010
[TBL] [Abstract][Full Text] [Related]
12. Cytopathologic diagnosis in pleural effusion and cyto-histopathologic correlation.
Dağli AF; Küçük S; Sezer M; Uçer O
Turk Patoloji Derg; 2011 Jan; 27(1):12-6. PubMed ID: 21469421
[TBL] [Abstract][Full Text] [Related]
13. Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens.
Tosun AB; Yergiyev O; Kolouri S; Silverman JF; Rohde GK
Cytometry A; 2015 Apr; 87(4):326-33. PubMed ID: 25598227
[TBL] [Abstract][Full Text] [Related]
14. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
15. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.
Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
J Clin Pathol; 2013 Oct; 66(10):847-53. PubMed ID: 23814259
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.
Rakha EA; Patil S; Abdulla K; Abdulkader M; Chaudry Z; Soomro IN
Diagn Cytopathol; 2010 Dec; 38(12):874-9. PubMed ID: 20049969
[TBL] [Abstract][Full Text] [Related]
18. Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.
Franceschini MC; Ferro P; Canessa PA; Battolla E; Dessanti P; Valentino A; Casolari L; Fontana V; Pezzi R; Fedeli F; Pistillo MP; Roncella S
Anticancer Res; 2014 Dec; 34(12):7425-9. PubMed ID: 25503183
[TBL] [Abstract][Full Text] [Related]
19. Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings.
Kawai T; Kawashima K; Serizawa H; Miura H; Kyeongil K
Diagn Cytopathol; 2014 May; 42(5):436-40. PubMed ID: 23166110
[TBL] [Abstract][Full Text] [Related]
20. Role of Cytology in the Current Guidelines for Malignant Mesothelioma: Largest Study from India.
Kaur K; Patel T; Samanta S; Patra S; Trivedi P
Acta Cytol; 2021; 65(2):175-185. PubMed ID: 33316798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
